by Anthony Chicotel, CANHR Staff Attorney
LeadingAge, an association of over 5,400 not-for-profit organizations including long-term care providers and aging services organizations, recently released a statement on antipsychotic drug use for dementia care. The statement clearly expresses LeadingAge’s opposition to inappropriate use of antipsychotics and calls for better treatment, using an interdisciplinary approach to provide true patient-centered care.
A very interesting piece of the LeadingAge statement is:
“if all nursing home providers and prescribers would adhere to the current regulations, as described in the Federal Register regarding avoiding unnecessary drugs and the adherence to gradual dose reductions, we would see a dramatic reduction in the use of these drugs.”
LeadingAge, with thousands of nursing homes among its membership, implicitly calls for increased adherence to regulatory rules to dramatically reduce the misuse of antipsychotic drugs in nursing homes. CANHR wholeheartedly agrees. CANHR recently made several recommendations to the state Department of Public Health to improve enforcement of the regulatory rules in its report about nursing home drugging.
We applaud LeadingAge for issuing this timely statement and look forward to hearing from its leaders about their efforts to reduce the misuse of antipsychotics among LeadingAge members.